Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced it is using the world’s top-ranked supercomputer and AI to investigate mechanisms of drug resistance in cancer treatments. Leveraging Fujitsu’s “Fugaku” HPC system, the new technology enables high-speed calculation of 20,000 variables of data in a day and is intended to find causal relationships […]